77 filings
Page 4 of 4
8-K
dbg6vbvrbrfxv
29 Jul 19
Rhythm Pharmaceuticals Reports Second Quarter 2019 Financial Results
4:40pm
8-K
pzvahyc4xni icr
25 Jul 19
Rhythm Pharmaceuticals Announces Appointment of Stuart Arbuckle to its Board of Directors
4:01pm
8-K
j6h1 jwcjkw
21 Jun 19
Submission of Matters to a Vote of Security Holders
4:10pm
8-K
cqvwoeb 4a8tosyx
23 May 19
Departure of Directors or Certain Officers
4:01pm
8-K
pzvbmu3mr1m0i4
3 May 19
Rhythm Pharmaceuticals Reports First Quarter 2019 Financial Results
5:08pm
8-K
rh2xl9 rv00n
28 Mar 19
Rhythm Pharmaceuticals Announces Promising Clinical Data in MC4R Pathway Heterozygous Obesity and Strategy for Further Development
4:00pm
8-K
jd825 okqij1j26j55yd
8 Mar 19
Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results
4:04pm
8-K
4gqlan3f6g3fchthg
8 Jan 19
Regulation FD Disclosure
12:00am
8-K
7bw2riou oebu3j7k
9 Nov 18
Management’s Discussion and Analysis of Financial Condition and Results of Operations
4:14pm
8-K
x3w17airptkn3eqln
9 Nov 18
Rhythm Pharmaceuticals Reports Third Quarter 2018 Financial Results
12:40pm
8-K
ae617gc vfdfvk
9 Aug 18
Rhythm Pharmaceuticals Reports Second Quarter 2018 Financial Results
4:07pm
8-K
z6746nuivam
11 Jun 18
Submission of Matters to a Vote of Security Holders
4:48pm
8-K
twfp8 m7k
14 May 18
Rhythm Pharmaceuticals Reports First Quarter 2018 Financial Results
4:01pm
8-K
99qfeiw8iy93q68kf98
2 Apr 18
Entry into a Material Definitive Agreement
12:00am
8-K
iw4omtttyqr92fh
14 Mar 18
Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results
12:00am
8-K
f9gxs5yvz0ivej
1 Nov 17
Rhythm Announces Preliminary Data from Phase 2 Study of Setmelanotide for Treatment of
12:00am
8-K
7jpviusw8z7u5oe0afk2
10 Oct 17
Rhythm Pharmaceuticals, Inc. Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
12:00am